1. TFOS Ambassadors

South Korea

Kyung Chul Yoon

Kyung Chul Yoon, MD, PhD is a Professor of the Department of Ophthalmology, Chonnam National University Medical School and Hospital and a Vice President of the Chonnam National University Hospital, Gwangju, South Korea. Following his residency at the Chonnam National University Hospital, he completed a fellowship at the Keio University School of Medicine, Japan, in 2004, and the Cullen Eye Institute of the Baylor College of Medicine, Houston, USA, in 2006–2007. Since 2004, he has been an Instructor, Assistant Professor, Associate Professor, and Professor at the Chonnam National University Medical School and Hospital.

Dr. Yoon specializes in tear film and ocular surface disorders, especially dry eye disease. He is one of the pioneers in the field of clinical and experimental dry eye research and has developed many drug delivery systems for dry eye treatment. He is an Editorial Board member of the Journal of Clinical Medicine, the Frontiers in Medicine, and the Annals of Optometry and Contact Lens and has published 360 scientific papers as well as 10 book chapters. 

Dr. Yoon is a president of the Korean Dry Eye Society and a previous president of the Korean Contact Lens Study Society. He is also an important director of the Korean Cornea Society and Korean Society of Cataract and Refractive Surgery and is a member of the Asia Dry Eye Advisory Board and Tear Film & Ocular Surface Society DEWS II & III. 
 
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members